LEROCHOL

Serial Number 98186146
Registration 8111583
700

Registration Progress

Application Filed
Sep 19, 2023
Under Examination
Aug 13, 2024
Approved for Publication
Jun 18, 2024
Published for Opposition
Jun 18, 2024
Registered
Jan 20, 2026

Trademark Image

LEROCHOL

Basic Information

Serial Number
98186146
Registration Number
8111583
Filing Date
September 19, 2023
Registration Date
January 20, 2026
Published for Opposition
June 18, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 20, 2026
Registration
Registered
Classes
005

Rights Holder

LIB THERAPEUTICS, INC.

03
Address
5375 MEDPACE WAY
CINCINNATI, OH 45227

Ownership History

LIB Therapeutics, LLC

Original Applicant
16
Cincinnati, OH

LIB Therapeutics, LLC

Owner at Publication
16
Cincinnati, OH

LIB THERAPEUTICS, INC.

New Owner After Publication #1
03
CINCINNATI, OH

LIB THERAPEUTICS, INC.

Original Registrant
03
CINCINNATI, OH

Legal Representation

Attorney
Michael A. Marrero

USPTO Deadlines

Next Deadline
2186 days remaining
Section 8 Declaration Due (Principal Register)
Due Date
January 20, 2032
Grace Period Ends
July 20, 2032

Application History

27 events
Date Code Type Description Documents
Jan 20, 2026 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 20, 2026 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 30, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Dec 30, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Dec 1, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jul 10, 2025 IUAF S USE AMENDMENT FILED Loading...
Aug 13, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 13, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 13, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 10, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jul 8, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 8, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 8, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 8, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 6, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 6, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 6, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 25, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Aug 13, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 18, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 18, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 29, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 15, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 13, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 4, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 21, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the prevention of high cholesterol; Pharmaceutical preparations for the treatment of high cholesterol
First Use Anywhere: Sep 30, 2024
First Use in Commerce: Sep 30, 2024

Classification

International Classes
005